LATE trial
Last reviewed 01/2018
This trial assessed the role of thrombolysis in patients with ECG-diagnosed myocardial infarction who present more than 6 hr after the onset of symptoms.
Thrombolysis up to 12 hr post-onset of symptoms was associated with improved survival.
Reference:
- LATE Study Group. (1993). Late assessment of thrombolysis efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction. Lancet, 342, 759-66.